ConductScience.org, home
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
API referenceFor AI assistants

Trial · NCT00000620

Adverse events72

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

21 to 40 of 72

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
seriousGastrointestinal bleedingGastrointestinal disordersGlycemia Trial: Intensive Control15,128
seriousGastrointestinal bleedingGastrointestinal disordersGlycemia Trial: Standard Control15,123
seriousPancreatitisEndocrine disordersGlycemia Trial: Intensive Control55,128
seriousPancreatitisEndocrine disordersGlycemia Trial: Standard Control85,123
seriousKetoacidosisEndocrine disordersGlycemia Trial: Intensive Control15,128
seriousKetoacidosisEndocrine disordersGlycemia Trial: Standard Control05,123
seriousHypoglycemia (fatal)Endocrine disordersGlycemia Trial: Intensive Control05,128
seriousHypoglycemia (fatal)Endocrine disordersGlycemia Trial: Standard Control15,123
seriousAcute or chronic renal failureRenal and urinary disordersGlycemia Trial: Intensive Control85,128
seriousAcute or chronic renal failureRenal and urinary disordersGlycemia Trial: Standard Control65,123
seriousAngioedemaImmune system disordersGlycemia Trial: Intensive Control95,128
seriousAngioedemaImmune system disordersGlycemia Trial: Standard Control45,123
seriousThrombocytopeniaImmune system disordersGlycemia Trial: Intensive Control25,128
seriousThrombocytopeniaImmune system disordersGlycemia Trial: Standard Control05,123
seriousBlood dyscrasiaImmune system disordersGlycemia Trial: Intensive Control15,128
seriousBlood dyscrasiaImmune system disordersGlycemia Trial: Standard Control05,123
seriousFelodipine toxicityImmune system disordersGlycemia Trial: Intensive Control15,128
seriousFelodipine toxicityImmune system disordersGlycemia Trial: Standard Control05,123
seriousMyositisMusculoskeletal and connective tissue disordersGlycemia Trial: Intensive Control25,128
seriousMyositisMusculoskeletal and connective tissue disordersGlycemia Trial: Standard Control35,123

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00000620/events?page=2

API referenceFor AI assistants